Where does Kevin Lind work?

Kevin Lind is Board Member at Avalo Therapeutics.

Where did Kevin Lind go to school?

Kevin Lind studied at MIT Sloan Executive Education (AI Pharma - Biotech, Artificial Intelligence); Boston College Carroll School of Management (MBA, MIS); Clark University (MCSE Windows 2000, Information Technology).

Kevin Lind

Investor

Board Member at Avalo Therapeutics · Vice President, Finance & Administration at Volta

Greater Boston

Find your path to Kevin

630 people in our graph share verified history with Kevin — schools, employers, funds. One of them is your warm intro.

Anthony PhilippakisunlockedKevin: together at Yale University (1998)

Kevin: together at Sherlock Biosciences

Kevin: together at Yale University

Kevin: together at Boston College

About

Seasoned biotechnology executive with over 20 years of leadership experience. Most recently President, CEO, and Board Member of Longboard Pharmaceuticals, leading its transformation and $2.6 billion acquisition by H. Lundbeck A/S in 2024. Previously Executive Vice President and CFO at Arena Pharmaceuticals. Career includes investment banking at Lehman Brothers and healthcare investing at TPG, with over a billion dollars in capital raised.

Experience

Soufflé TherapeuticsAssociate Director ITcurrent2025 — presentWatertown, Massachusetts, United States
Landmark BioAssociate Director - Digital Platforms2023 — 2025Watertown, Massachusetts, United States
Sherlock BiosciencesSr. Manager, IT Sherlock Biosciences2021 — 2023Boston, Massachusetts, United States
PharmaEssentiaSr. IT Manager2020 — 2021United States
AgenusInformation Technology Manager2018 — 2020Lexington, Massachusetts
Repligen CorporationIT Operations Manager2016 — 2018Waltham, MA
The Cadmus GroupIT Operations Manager2011 — 2016Watertown, MA
Rue La LaInfrastructure Engineer2010 — 2011Boston, Massachusetts, United States
Thrive NetworksNetwork Engineer, Thrive Networks2008 — 2010Boston, Massachusetts, United States
Boston CollegeTechnology Consultant2003 — 2008Greater Boston
Fidelity InvestmentsSystems Analyst, Market Data2001 — 2003
TEKsystems IT & Communications Strategic Staffing, IncConsultant2001

Skills & more

Artificial Intelligence (AI)Machine LearningSecurityOffice 365 AdministrationData GovernanceData WarehousingCRO ManagementMicrosoft IntuneNISTElectronic Lab NotebooksSpam FilteringAnti-spam

+12 more

Sarbanes-Oxley ActmdmPolicies & ProceduresRegulatory RequirementsLife Science IndustryGxPBioinformatics21 CFRmfaVeeva CRMSAP ERPLearning Management Systems

RLF — SIM Boston

From Kevin's professional profile.

Colleagues at Avalo Therapeutics

Aaron Kantoff

Board Member at Avalo Therapeutics

Aaron Kantoff

Managing Partner at Scion Life Sciences

Amy Conrad

Senior Events Manager at Volta Labs

Ashley Ivanowicz

Senior Vice President, Human Resources at Avalo Therapeutics

Chris Sullivan

Chief Financial Officer at Avalo Therapeutics

Colleen Matkowski

Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics

Dino C. Miano

Senior Vice President, CMC and Technical Operations at Avalo Therapeutics

Garrett Lauderdale

Vice President at Idea of La Crosse

Frequently asked questions

Who is Kevin Lind?: Seasoned biotechnology executive with over 20 years of leadership experience. Most recently President, CEO, and Board Member of Longboard Pharmaceuticals, leading its transformation and $2.6 billion acquisition by H. Lundbeck A/S in 2024. Previously Executive Vice President and CFO at Arena Pharmaceuticals. Career includes investment banking at Lehman Brothers and healthcare investing at TPG, with over a billion dollars in capital raised.
Where does Kevin Lind work?: Kevin Lind is Board Member at Avalo Therapeutics.
Where did Kevin Lind go to school?: Kevin Lind studied at MIT Sloan Executive Education (AI Pharma - Biotech, Artificial Intelligence); Boston College Carroll School of Management (MBA, MIS); Clark University (MCSE Windows 2000, Information Technology).